PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
36.47%
Some net income increase while CSIQ is negative at -63.77%. John Neff would see a short-term edge over the struggling competitor.
3.64%
Some D&A expansion while CSIQ is negative at -100.00%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-102.85%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
0.27%
Less SBC growth vs. CSIQ's 79.21%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-48.13%
Both reduce yoy usage, with CSIQ at -100.00%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-36.05%
AR is negative yoy while CSIQ is 100.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
63.94%
Some inventory rise while CSIQ is negative at -100.00%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
-176.98%
Negative yoy AP while CSIQ is 100.00%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
10.27%
Some yoy usage while CSIQ is negative at -100.00%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
117.59%
Some yoy increase while CSIQ is negative at -511.42%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-24.60%
Both yoy CFO lines are negative, with CSIQ at -100.00%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
42.23%
Lower CapEx growth vs. CSIQ's 100.00%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
-111.59%
Negative yoy acquisition while CSIQ stands at 100.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
11.90%
We have some outflow growth while CSIQ is negative at -100.00%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-297.77%
We reduce yoy invests while CSIQ stands at 100.00%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
580.36%
Debt repayment above 1.5x CSIQ's 100.00%, indicating stronger deleveraging. David Dodd would verify if expansions are not neglected.
No Data
No Data available this quarter, please select a different quarter.
-1274.80%
We cut yoy buybacks while CSIQ is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.